AANA Journal Course: Anesthesia and Peri-Operative Considerations for Patients with Myasthenia Gravis

Add to Cart

Members

Non-Members

$50.00

+ Add to Cart

Class A Credits: 1.0

Format: PDF

Course Launch Date: 12/18/20

Course Expires: 12/17/23

Member/Associate: $0.00

Non-Member: $50.00

The purpose of this activity is for the learner to become more familiar with performing a thorough preoperative assessment, creating a patient-oriented care plan that addresses the specific needs of a patient with myasthenia gravis.  Consideration of risk factors that can lead to postoperative myasthenic crises should be screened for, such as previous history of myasthenic crisis, preoperative MGFA class, bulbar symptoms, and presence of thymoma.    

The American Association of Nurse Anesthetists is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.


Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:

The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.

  • Summarize the pathophysiology underlying myasthenia gravis.
  • Explain factors that contribute to myasthenic and cholinergic crises.
  • Describe the implications that immunosuppressants and anticholinesterase inhibitors (AChIs) have on neuromuscular blockade.
  • Compare the advantages of using sugammadex versus AChIs in patients with myasthenia gravis.
  • Identify the risk factors associated with postoperative myasthenic crisis.
  • Describe the specific considerations involving postoperative management.

Howard Roberts, MS, CRNA



Ian Hewer, PhD, CRNA



Shawn Collins, DNP, PhD, CRNA


rocket-idle